Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer (Q34302904)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer |
scientific article |
Statements
1 reference
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer (English)
1 reference
Y Matsumura
1 reference
M Gotoh
1 reference
K Muro
1 reference
Y Yamada
1 reference
K Shirao
1 reference
Y Shimada
1 reference
M Okuwa
1 reference
S Matsumoto
1 reference
Y Miyata
1 reference
H Ohkura
1 reference
K Chin
1 reference
S Baba
1 reference
T Yamao
1 reference
A Kannami
1 reference
Y Takamatsu
1 reference
K Ito
1 reference
K Takahashi
1 reference
1 March 2004
1 reference
1 reference
15
1 reference
3
1 reference
517-525
1 reference
Identifiers
1 reference
1 reference